245 related articles for article (PubMed ID: 32607548)
1. Prostate cancer early diagnosis: circulating microRNA pairs potentially beyond single microRNAs upon 1231 serum samples.
Liu HP; Lai HM; Guo Z
Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32607548
[TBL] [Abstract][Full Text] [Related]
2. Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer.
Urabe F; Matsuzaki J; Yamamoto Y; Kimura T; Hara T; Ichikawa M; Takizawa S; Aoki Y; Niida S; Sakamoto H; Kato K; Egawa S; Fujimoto H; Ochiya T
Clin Cancer Res; 2019 May; 25(10):3016-3025. PubMed ID: 30808771
[TBL] [Abstract][Full Text] [Related]
3. Circulating microRNA signature for the diagnosis of very high-risk prostate cancer.
Alhasan AH; Scott AW; Wu JJ; Feng G; Meeks JJ; Thaxton CS; Mirkin CA
Proc Natl Acad Sci U S A; 2016 Sep; 113(38):10655-60. PubMed ID: 27601638
[TBL] [Abstract][Full Text] [Related]
4. Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia.
Jin W; Fei X; Wang X; Chen F; Song Y
J Immunol Res; 2020; 2020():5873056. PubMed ID: 32455140
[TBL] [Abstract][Full Text] [Related]
5. Discovery and Validation of Serum MicroRNAs as Early Diagnostic Biomarkers for Prostate Cancer in Chinese Population.
Lyu J; Zhao L; Wang F; Ji J; Cao Z; Xu H; Shi X; Zhu Y; Zhang C; Guo F; Yang B; Sun Y
Biomed Res Int; 2019; 2019():9306803. PubMed ID: 31534967
[TBL] [Abstract][Full Text] [Related]
6. Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in prostate cancer: Current status and future perspectives.
Movahedpour A; Ahmadi N; Ghasemi Y; Savardashtaki A; Shabaninejad Z
J Cell Biochem; 2019 Oct; 120(10):16316-16329. PubMed ID: 31257636
[TBL] [Abstract][Full Text] [Related]
7. Circulating microRNAs in plasma as potential biomarkers for the early detection of prostate cancer.
McDonald AC; Vira M; Shen J; Sanda M; Raman JD; Liao J; Patil D; Taioli E
Prostate; 2018 May; 78(6):411-418. PubMed ID: 29383739
[TBL] [Abstract][Full Text] [Related]
8. Single-molecule amplification-free multiplexed detection of circulating microRNA cancer biomarkers from serum.
Cai S; Pataillot-Meakin T; Shibakawa A; Ren R; Bevan CL; Ladame S; Ivanov AP; Edel JB
Nat Commun; 2021 Jun; 12(1):3515. PubMed ID: 34112774
[TBL] [Abstract][Full Text] [Related]
9. Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome.
Juracek J; Madrzyk M; Trachtova K; Ruckova M; Bohosova J; Barth DA; Pichler M; Stanik M; Slaby O
Cancer Genomics Proteomics; 2023; 20(3):308-316. PubMed ID: 37093688
[TBL] [Abstract][Full Text] [Related]
10. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
Barceló M; Castells M; Bassas L; Vigués F; Larriba S
Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
[TBL] [Abstract][Full Text] [Related]
11. Circulating miR-20a and miR-26a as Biomarkers in Prostate Cancer.
Mohammadi Torbati P; Asadi F; Fard-Esfahani P
Asian Pac J Cancer Prev; 2019 May; 20(5):1453-1456. PubMed ID: 31127907
[TBL] [Abstract][Full Text] [Related]
12. Implications of microRNA dysregulation in the development of prostate cancer.
Massillo C; Dalton GN; Farré PL; De Luca P; De Siervi A
Reproduction; 2017 Oct; 154(4):R81-R97. PubMed ID: 28878093
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-Based Method for the Identification of Novel MicroRNA Biomarkers in Prostate Cancer.
Cornice J; Capece D; Di Vito Nolfi M; Di Padova M; Compagnoni C; Verzella D; Di Francesco B; Vecchiotti D; Flati I; Tessitore A; Alesse E; Barbato G; Zazzeroni F
Genes (Basel); 2021 Oct; 12(11):. PubMed ID: 34828332
[TBL] [Abstract][Full Text] [Related]
14. Circulating mRNAs and miRNAs as candidate markers for the diagnosis and prognosis of prostate cancer.
Souza MF; Kuasne H; Barros-Filho MC; Cilião HL; Marchi FA; Fuganti PE; Paschoal AR; Rogatto SR; Cólus IMS
PLoS One; 2017; 12(9):e0184094. PubMed ID: 28910345
[TBL] [Abstract][Full Text] [Related]
15. Assessment of Serum microRNA Biomarkers to Predict Reclassification of Prostate Cancer in Patients on Active Surveillance.
Liu RSC; Olkhov-Mitsel E; Jeyapala R; Zhao F; Commisso K; Klotz L; Loblaw A; Liu SK; Vesprini D; Fleshner NE; Bapat B
J Urol; 2018 Jun; 199(6):1475-1481. PubMed ID: 29246734
[TBL] [Abstract][Full Text] [Related]
16. Circulating microRNAs in plasma before and after radical prostatectomy.
McDonald AC; Raman JD; Shen J; Liao J; Pandya B; Vira MA
Urol Oncol; 2019 Nov; 37(11):814.e1-814.e7. PubMed ID: 31421994
[TBL] [Abstract][Full Text] [Related]
17. A circulating miRNA assay as a first-line test for prostate cancer screening.
Sharova E; Grassi A; Marcer A; Ruggero K; Pinto F; Bassi P; Zanovello P; Zattoni F; D'Agostino DM; Iafrate M; Ciminale V
Br J Cancer; 2016 Jun; 114(12):1362-6. PubMed ID: 27228285
[TBL] [Abstract][Full Text] [Related]
18. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
19. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients.
Endzeliņš E; Berger A; Melne V; Bajo-Santos C; Soboļevska K; Ābols A; Rodriguez M; Šantare D; Rudņickiha A; Lietuvietis V; Llorente A; Linē A
BMC Cancer; 2017 Nov; 17(1):730. PubMed ID: 29121858
[TBL] [Abstract][Full Text] [Related]
20. A Tetra-Panel of Serum Circulating miRNAs for the Diagnosis of the Four Most Prevalent Tumor Types.
Pastor-Navarro B; García-Flores M; Fernández-Serra A; Blanch-Tormo S; Martínez de Juan F; Martínez-Lapiedra C; Maia de Alcantara F; Peñalver JC; Cervera-Deval J; Rubio-Briones J; García-Rupérez J; López-Guerrero JA
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32316350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]